Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM - Euronext Paris - Matif - FR0013154002 - Common Stock - Currency: EUR

193.1  -3.95 (-2%)

Fundamental Rating

4

DIM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 17 industry peers in the Life Sciences Tools & Services industry. DIM has an average financial health and profitability rating. While showing a medium growth rate, DIM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DIM had positive earnings in the past year.
DIM had a positive operating cash flow in the past year.
In the past 5 years DIM has always been profitable.
Each year in the past 5 years DIM had a positive operating cash flow.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

With a Return On Assets value of 2.12%, DIM perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
With a Return On Equity value of 4.38%, DIM perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.03%, DIM is doing worse than 70.59% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DIM is above the industry average of 7.23%.
The 3 year average ROIC (10.41%) for DIM is well above the current ROIC(4.03%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.12%
ROE 4.38%
ROIC 4.03%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

DIM has a better Profit Margin (6.29%) than 64.71% of its industry peers.
DIM's Profit Margin has declined in the last couple of years.
The Operating Margin of DIM (13.32%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DIM has declined.
DIM's Gross Margin of 43.40% is in line compared to the rest of the industry. DIM outperforms 52.94% of its industry peers.
In the last couple of years the Gross Margin of DIM has declined.
Industry RankSector Rank
OM 13.32%
PM (TTM) 6.29%
GM 43.4%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DIM is creating some value.
DIM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DIM has been increased compared to 5 years ago.
DIM has a better debt/assets ratio than last year.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.91 indicates that DIM is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.91, DIM perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
DIM has a debt to FCF ratio of 6.04. This is a slightly negative value and a sign of low solvency as DIM would need 6.04 years to pay back of all of its debts.
DIM has a Debt to FCF ratio of 6.04. This is in the lower half of the industry: DIM underperforms 64.71% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that DIM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, DIM is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 6.04
Altman-Z 3.91
ROIC/WACC0.52
WACC7.81%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

DIM has a Current Ratio of 1.85. This is a normal value and indicates that DIM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DIM (1.85) is better than 64.71% of its industry peers.
DIM has a Quick Ratio of 1.12. This is a normal value and indicates that DIM is financially healthy and should not expect problems in meeting its short term obligations.
DIM has a Quick ratio (1.12) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.12
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

DIM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.47%.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
Looking at the last year, DIM shows a small growth in Revenue. The Revenue has grown by 0.16% in the last year.
Measured over the past years, DIM shows a quite strong growth in Revenue. The Revenue has been growing by 14.05% on average per year.
EPS 1Y (TTM)-16.47%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%43.06%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%6.3%

3.2 Future

The Earnings Per Share is expected to grow by 22.18% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.44% on average over the next years. This is quite good.
EPS Next Y24.02%
EPS Next 2Y24.95%
EPS Next 3Y24.29%
EPS Next 5Y22.18%
Revenue Next Year9.64%
Revenue Next 2Y10.58%
Revenue Next 3Y10.89%
Revenue Next 5Y12.44%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DIM is valuated quite expensively with a Price/Earnings ratio of 55.17.
82.35% of the companies in the same industry are cheaper than DIM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of DIM to the average of the S&P500 Index (29.35), we can say DIM is valued expensively.
The Price/Forward Earnings ratio is 44.49, which means the current valuation is very expensive for DIM.
76.47% of the companies in the same industry are cheaper than DIM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, DIM is valued quite expensively.
Industry RankSector Rank
PE 55.17
Fwd PE 44.49
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DIM indicates a rather expensive valuation: DIM more expensive than 82.35% of the companies listed in the same industry.
DIM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. DIM is more expensive than 70.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.54
EV/EBITDA 31.2
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DIM's earnings are expected to grow with 24.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.3
PEG (5Y)13.15
EPS Next 2Y24.95%
EPS Next 3Y24.29%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.35%, DIM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.77, DIM is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.33, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.35%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years2
Div Non Decr Years2
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

DIM pays out 38.39% of its income as dividend. This is a sustainable payout ratio.
DIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.39%
EPS Next 2Y24.95%
EPS Next 3Y24.29%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (3/7/2025, 7:00:00 PM)

193.1

-3.95 (-2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)04-16 2025-04-16
Inst Owners11.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.79B
Analysts76.67
Price Target257.35 (33.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.35%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP38.39%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.01%
Min EPS beat(2)-5.62%
Max EPS beat(2)7.63%
EPS beat(4)1
Avg EPS beat(4)-6.92%
Min EPS beat(4)-20.27%
Max EPS beat(4)7.63%
EPS beat(8)1
Avg EPS beat(8)-19.76%
EPS beat(12)1
Avg EPS beat(12)-20.47%
EPS beat(16)5
Avg EPS beat(16)-12.49%
Revenue beat(2)1
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-5.11%
Max Revenue beat(2)2.91%
Revenue beat(4)2
Avg Revenue beat(4)-2.22%
Min Revenue beat(4)-8.16%
Max Revenue beat(4)2.91%
Revenue beat(8)3
Avg Revenue beat(8)-1.91%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)8
Avg Revenue beat(16)12.76%
PT rev (1m)14.45%
PT rev (3m)17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.28%
EPS NY rev (1m)1.27%
EPS NY rev (3m)-0.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.21%
Revenue NY rev (1m)1.16%
Revenue NY rev (3m)0.76%
Valuation
Industry RankSector Rank
PE 55.17
Fwd PE 44.49
P/S 6.76
P/FCF 39.54
P/OCF 23.06
P/B 4.71
P/tB N/A
EV/EBITDA 31.2
EPS(TTM)3.5
EY1.81%
EPS(NY)4.34
Fwd EY2.25%
FCF(TTM)4.88
FCFY2.53%
OCF(TTM)8.37
OCFY4.34%
SpS28.56
BVpS40.96
TBVpS-5.68
PEG (NY)2.3
PEG (5Y)13.15
Profitability
Industry RankSector Rank
ROA 2.12%
ROE 4.38%
ROCE 5.06%
ROIC 4.03%
ROICexc 4.45%
ROICexgc 14.12%
OM 13.32%
PM (TTM) 6.29%
GM 43.4%
FCFM 17.1%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 6.04
Debt/EBITDA 4.17
Cap/Depr 112.63%
Cap/Sales 12.22%
Interest Coverage 2.09
Cash Conversion 121.31%
Profit Quality 271.91%
Current Ratio 1.85
Quick Ratio 1.12
Altman-Z 3.91
F-Score5
WACC7.81%
ROIC/WACC0.52
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.47%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%43.06%
EPS Next Y24.02%
EPS Next 2Y24.95%
EPS Next 3Y24.29%
EPS Next 5Y22.18%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%6.3%
Revenue Next Year9.64%
Revenue Next 2Y10.58%
Revenue Next 3Y10.89%
Revenue Next 5Y12.44%
EBIT growth 1Y-17.48%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year87.53%
EBIT Next 3Y36.62%
EBIT Next 5Y29.52%
FCF growth 1Y74.23%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y9.2%
OCF growth 3Y5.11%
OCF growth 5Y21.32%